Market Executive Summary
The global Immunoglobulin market size was US$ 8538.2 million in 2022 and is forecast to a readjusted size of US$ 12290 million by 2029 with a CAGR of 5.3% during the forecast period 2023-2029.
The global key manufacturers of Immunoglobulin include Baxter, CSL, Grifols, Octapharma, Biotest, China National Pharmaceutical Group, CTBB, Hualan Bio and RAAS, etc. In 2022, the global top five players hold a share approximately % in sales volume, and in term of revenue of Immunoglobulin, the top five companies hold a share nearly %.
In terms of sales (consumption) side, this report focuses on the sales of Immunoglobulin by regions (Countries), company, by type and by type. from 2018 to 2023 and forecast to 2029.
The global Immunoglobulin market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of sales analysis, the authors of the report have provided reliable estimations and calculations for global revenue and sales by type segment of the global Immunoglobulin market. These figures have been provided in terms of both revenue and sales for the period 2018-2029. Additionally, the report provides accurate figures for sales by region in terms of revenue as well as volume for the same period.
By Company
Baxter
CSL
Grifols
Octapharma
Biotest
China National Pharmaceutical Group
CTBB
Hualan Bio
RAAS
Shanxi Kangbao Biological
Shuanglin Bio Pharm
Sichuan Yuanda Shuyang Pharmaceutical
Boya Bio
Jiade Bio
Weilun Bio
By Type
Intramuscular Injection Human Immunoglobulin
Intravenous Injection Human Immunoglobulin
By Application
Prevention of Measles
Infectious Hepatitis
Primary Immunoglobulin Deficiency
Sales by Region
North America
U.S.
Canada
China
APAC (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Middle East, Africa, Latin America
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Immunoglobulin in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of Immunoglobulin manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 7: Europe by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 8: China by company, by type and by application, sales, and revenue for each segment.
Chapter 9: APAC (excluding China) by company, by type, by application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Immunoglobulin sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
Table of Contents
1 Report Overview
1.1 Immunoglobulin Definition
1.2 Market by Type
1.2.1 Global Immunoglobulin Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Intramuscular Injection Human Immunoglobulin
1.2.3 Intravenous Injection Human Immunoglobulin
1.3 Market Segment by Application
1.3.1 Global Immunoglobulin Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Prevention of Measles
1.3.3 Infectious Hepatitis
1.3.4 Primary Immunoglobulin Deficiency
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Immunoglobulin Sales
2.1 Global Immunoglobulin Revenue Estimates and Forecasts 2018-2029
2.2 Global Immunoglobulin Revenue by Region: 2018 VS 2022 VS 2029
2.3 Global Immunoglobulin Revenue by Region
2.3.1 Global Immunoglobulin Revenue by Region (2018-2023)
2.3.2 Global Immunoglobulin Revenue by Region (2024-2029)
2.4 Global Immunoglobulin Sales Quantity Estimates and Forecasts 2018-2029
2.5 Global Immunoglobulin Sales Quantity by Region: 2018 VS 2022 VS 2029
2.6 Global Immunoglobulin Sales Quantity by Region
2.6.1 Global Immunoglobulin Sales Quantity by Region (2018-2023)
2.6.2 Global Immunoglobulin Sales Quantity by Region (2024-2029)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Immunoglobulin Sales Quantity by Manufacturers
3.1.1 Global Immunoglobulin Sales Quantity by Manufacturers (2018-2023)
3.1.2 Global Immunoglobulin Sales Quantity Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Companies by Immunoglobulin Sales in 2022
3.2 Global Immunoglobulin Revenue by Manufacturers
3.2.1 Global Immunoglobulin Revenue by Manufacturers (2018-2023)
3.2.2 Global Immunoglobulin Revenue Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Immunoglobulin Revenue in 2022
3.3 Global Immunoglobulin Sales Price by Manufacturers
3.4 Global Key Players of Immunoglobulin, Industry Ranking, 2021 VS 2022
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Immunoglobulin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Immunoglobulin, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Immunoglobulin, Product Offered and Application
3.8 Global Key Manufacturers of Immunoglobulin, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Estimates and Forecasts by Type
4.1 Global Immunoglobulin Sales Quantity by Type
4.1.1 Global Immunoglobulin Historical Sales Quantity by Type (2018-2023)
4.1.2 Global Immunoglobulin Forecasted Sales Quantity by Type (2024-2029)
4.1.3 Global Immunoglobulin Sales Quantity Market Share by Type (2018-2029)
4.2 Global Immunoglobulin Revenue by Type
4.2.1 Global Immunoglobulin Historical Revenue by Type (2018-2023)
4.2.2 Global Immunoglobulin Forecasted Revenue by Type (2024-2029)
4.2.3 Global Immunoglobulin Revenue Market Share by Type (2018-2029)
4.3 Global Immunoglobulin Price by Type
4.3.1 Global Immunoglobulin Price by Type (2018-2023)
4.3.2 Global Immunoglobulin Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Immunoglobulin Sales Quantity by Application
5.1.1 Global Immunoglobulin Historical Sales Quantity by Application (2018-2023)
5.1.2 Global Immunoglobulin Forecasted Sales Quantity by Application (2024-2029)
5.1.3 Global Immunoglobulin Sales Quantity Market Share by Application (2018-2029)
5.2 Global Immunoglobulin Revenue by Application
5.2.1 Global Immunoglobulin Historical Revenue by Application (2018-2023)
5.2.2 Global Immunoglobulin Forecasted Revenue by Application (2024-2029)
5.2.3 Global Immunoglobulin Revenue Market Share by Application (2018-2029)
5.3 Global Immunoglobulin Price by Application
5.3.1 Global Immunoglobulin Price by Application (2018-2023)
5.3.2 Global Immunoglobulin Price Forecast by Application (2024-2029)
6 North America
6.1 North America Immunoglobulin Sales by Company
6.1.1 North America Immunoglobulin Revenue by Company (2018-2023)
6.1.2 North America Immunoglobulin Sales Quantity by Company (2018-2023)
6.2 North America Immunoglobulin Market Size by Type
6.2.1 North America Immunoglobulin Sales Quantity by Type (2018-2029)
6.2.2 North America Immunoglobulin Revenue by Type (2018-2029)
6.3 North America Immunoglobulin Market Size by Application
6.3.1 North America Immunoglobulin Sales Quantity by Application (2018-2029)
6.3.2 North America Immunoglobulin Revenue by Application (2018-2029)
6.4 North America Immunoglobulin Market Size by Country
6.4.1 North America Immunoglobulin Revenue by Country: 2018 VS 2022 VS 2029
6.4.2 North America Immunoglobulin Revenue by Country (2018-2029)
6.4.3 North America Immunoglobulin Sales Quantity by Country (2018-2029)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Immunoglobulin Sales by Company
7.1.1 Europe Immunoglobulin Sales Quantity by Company (2018-2023)
7.1.2 Europe Immunoglobulin Revenue by Company (2018-2023)
7.2 Europe Immunoglobulin Market Size by Type
7.2.1 Europe Immunoglobulin Sales Quantity by Type (2018-2029)
7.2.2 Europe Immunoglobulin Revenue by Type (2018-2029)
7.3 Europe Immunoglobulin Market Size by Application
7.3.1 Europe Immunoglobulin Sales Quantity by Application (2018-2029)
7.3.2 Europe Immunoglobulin Revenue by Application (2018-2029)
7.4 Europe Immunoglobulin Market Size by Country
7.4.1 Europe Immunoglobulin Revenue by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Immunoglobulin Revenue by Country (2018-2029)
7.4.3 Europe Immunoglobulin Sales Quantity by Country (2018-2029)
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China Immunoglobulin Sales by Company
8.1.1 China Immunoglobulin Sales Quantity by Company (2018-2023)
8.1.2 China Immunoglobulin Revenue by Company (2018-2023)
8.2 China Immunoglobulin Market Size by Type
8.2.1 China Immunoglobulin Sales Quantity by Type (2018-2029)
8.2.2 China Immunoglobulin Revenue by Type (2018-2029)
8.3 China Immunoglobulin Market Size by Application
8.3.1 China Immunoglobulin Sales Quantity by Application (2018-2029)
8.3.2 China Immunoglobulin Revenue by Application (2018-2029)
9 APAC (excluding China)
9.1 APAC Immunoglobulin Sales by Company
9.1.1 APAC Immunoglobulin Sales Quantity by Company (2018-2023)
9.1.2 APAC Immunoglobulin Revenue by Company (2018-2023)
9.2 APAC Immunoglobulin Market Size by Type
9.2.1 APAC Immunoglobulin Sales Quantity by Type (2018-2029)
9.2.2 APAC Immunoglobulin Revenue by Type (2018-2029)
9.3 APAC Immunoglobulin Market Size by Application
9.3.1 APAC Immunoglobulin Sales Quantity by Application (2018-2029)
9.3.2 APAC Immunoglobulin Revenue by Application (2018-2029)
9.4 APAC Immunoglobulin Market Size by Region
9.4.1 APAC Immunoglobulin Revenue by Region: 2018 VS 2022 VS 2029
9.4.2 APAC Immunoglobulin Revenue by Region (2018-2029)
9.4.3 APAC Immunoglobulin Sales Quantity by Region (2018-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Immunoglobulin Sales by Company
10.1.1 Middle East, Africa and Latin America Immunoglobulin Sales Quantity by Company (2018-2023)
10.1.2 Middle East, Africa and Latin America Immunoglobulin Revenue by Company (2018-2023)
10.2 Middle East, Africa and Latin America Immunoglobulin Market Size by Type
10.2.1 Middle East, Africa and Latin America Immunoglobulin Sales Quantity by Type (2018-2029)
10.2.2 Middle East, Africa and Latin America Immunoglobulin Revenue by Type (2018-2029)
10.3 Middle East, Africa and Latin America Immunoglobulin Market Size by Application
10.3.1 Middle East, Africa and Latin America Immunoglobulin Sales Quantity by Application (2018-2029)
10.3.2 Middle East, Africa and Latin America Immunoglobulin Revenue by Application (2018-2029)
10.4 Middle East, Africa and Latin America Immunoglobulin Market Size by Country
10.4.1 Middle East, Africa and Latin America Immunoglobulin Revenue by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa and Latin America Immunoglobulin Revenue by Country (2018-2029)
10.4.3 Middle East, Africa and Latin America Immunoglobulin Sales Quantity by Country (2018-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 GCC Countries
11 Company Profiles
11.1 Baxter
11.1.1 Baxter Company Information
11.1.2 Baxter Overview
11.1.3 Baxter Immunoglobulin Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.1.4 Baxter Immunoglobulin Products and Services
11.1.5 Baxter Immunoglobulin SWOT Analysis
11.1.6 Baxter Recent Developments
11.2 CSL
11.2.1 CSL Company Information
11.2.2 CSL Overview
11.2.3 CSL Immunoglobulin Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.2.4 CSL Immunoglobulin Products and Services
11.2.5 CSL Immunoglobulin SWOT Analysis
11.2.6 CSL Recent Developments
11.3 Grifols
11.3.1 Grifols Company Information
11.3.2 Grifols Overview
11.3.3 Grifols Immunoglobulin Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.3.4 Grifols Immunoglobulin Products and Services
11.3.5 Grifols Immunoglobulin SWOT Analysis
11.3.6 Grifols Recent Developments
11.4 Octapharma
11.4.1 Octapharma Company Information
11.4.2 Octapharma Overview
11.4.3 Octapharma Immunoglobulin Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.4.4 Octapharma Immunoglobulin Products and Services
11.4.5 Octapharma Immunoglobulin SWOT Analysis
11.4.6 Octapharma Recent Developments
11.5 Biotest
11.5.1 Biotest Company Information
11.5.2 Biotest Overview
11.5.3 Biotest Immunoglobulin Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.5.4 Biotest Immunoglobulin Products and Services
11.5.5 Biotest Immunoglobulin SWOT Analysis
11.5.6 Biotest Recent Developments
11.6 China National Pharmaceutical Group
11.6.1 China National Pharmaceutical Group Company Information
11.6.2 China National Pharmaceutical Group Overview
11.6.3 China National Pharmaceutical Group Immunoglobulin Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.6.4 China National Pharmaceutical Group Immunoglobulin Products and Services
11.6.5 China National Pharmaceutical Group Immunoglobulin SWOT Analysis
11.6.6 China National Pharmaceutical Group Recent Developments
11.7 CTBB
11.7.1 CTBB Company Information
11.7.2 CTBB Overview
11.7.3 CTBB Immunoglobulin Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.7.4 CTBB Immunoglobulin Products and Services
11.7.5 CTBB Immunoglobulin SWOT Analysis
11.7.6 CTBB Recent Developments
11.8 Hualan Bio
11.8.1 Hualan Bio Company Information
11.8.2 Hualan Bio Overview
11.8.3 Hualan Bio Immunoglobulin Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.8.4 Hualan Bio Immunoglobulin Products and Services
11.8.5 Hualan Bio Immunoglobulin SWOT Analysis
11.8.6 Hualan Bio Recent Developments
11.9 RAAS
11.9.1 RAAS Company Information
11.9.2 RAAS Overview
11.9.3 RAAS Immunoglobulin Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.9.4 RAAS Immunoglobulin Products and Services
11.9.5 RAAS Immunoglobulin SWOT Analysis
11.9.6 RAAS Recent Developments
11.10 Shanxi Kangbao Biological
11.10.1 Shanxi Kangbao Biological Company Information
11.10.2 Shanxi Kangbao Biological Overview
11.10.3 Shanxi Kangbao Biological Immunoglobulin Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.10.4 Shanxi Kangbao Biological Immunoglobulin Products and Services
11.10.5 Shanxi Kangbao Biological Immunoglobulin SWOT Analysis
11.10.6 Shanxi Kangbao Biological Recent Developments
11.11 Shuanglin Bio Pharm
11.11.1 Shuanglin Bio Pharm Company Information
11.11.2 Shuanglin Bio Pharm Overview
11.11.3 Shuanglin Bio Pharm Immunoglobulin Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.11.4 Shuanglin Bio Pharm Immunoglobulin Products and Services
11.11.5 Shuanglin Bio Pharm Recent Developments
11.12 Sichuan Yuanda Shuyang Pharmaceutical
11.12.1 Sichuan Yuanda Shuyang Pharmaceutical Company Information
11.12.2 Sichuan Yuanda Shuyang Pharmaceutical Overview
11.12.3 Sichuan Yuanda Shuyang Pharmaceutical Immunoglobulin Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.12.4 Sichuan Yuanda Shuyang Pharmaceutical Immunoglobulin Products and Services
11.12.5 Sichuan Yuanda Shuyang Pharmaceutical Recent Developments
11.13 Boya Bio
11.13.1 Boya Bio Company Information
11.13.2 Boya Bio Overview
11.13.3 Boya Bio Immunoglobulin Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.13.4 Boya Bio Immunoglobulin Products and Services
11.13.5 Boya Bio Recent Developments
11.14 Jiade Bio
11.14.1 Jiade Bio Company Information
11.14.2 Jiade Bio Overview
11.14.3 Jiade Bio Immunoglobulin Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.14.4 Jiade Bio Immunoglobulin Products and Services
11.14.5 Jiade Bio Recent Developments
11.15 Weilun Bio
11.15.1 Weilun Bio Company Information
11.15.2 Weilun Bio Overview
11.15.3 Weilun Bio Immunoglobulin Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.15.4 Weilun Bio Immunoglobulin Products and Services
11.15.5 Weilun Bio Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Immunoglobulin Value Chain Analysis
12.2 Immunoglobulin Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Immunoglobulin Production Mode & Process
12.4 Immunoglobulin Sales and Marketing
12.4.1 Immunoglobulin Sales Channels
12.4.2 Immunoglobulin Distributors
12.5 Immunoglobulin Customers
13 Market Dynamics
13.1 Immunoglobulin Industry Trends
13.2 Immunoglobulin Market Drivers
13.3 Immunoglobulin Market Challenges
13.4 Immunoglobulin Market Restraints
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Figures
List of Tables
Table 1. Global Immunoglobulin Market Size Growth Rate (CAGR) by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Intramuscular Injection Human Immunoglobulin
Table 3. Major Manufacturers of Intravenous Injection Human Immunoglobulin
Table 4. Global Immunoglobulin Market Size Growth Rate (CAGR) by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Immunoglobulin Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Immunoglobulin Revenue by Region (2018-2023) & (US$ Million)
Table 7. Global Immunoglobulin Revenue Market Share by Region (2018-2023)
Table 8. Global Immunoglobulin Revenue by Region (2024-2029) & (US$ Million)
Table 9. Global Immunoglobulin Revenue Market Share by Region (2024-2029)
Table 10. Global Immunoglobulin Sales Quantity by Region: 2018 VS 2022 VS 2029 (K Pcs)
Table 11. Global Immunoglobulin Sales by Region (2018-2023) & (K Pcs)
Table 12. Global Immunoglobulin Sales Market Share by Region (2018-2023)
Table 13. Global Immunoglobulin Sales by Region (2024-2029) & (K Pcs)
Table 14. Global Immunoglobulin Sales Market Share by Region (2024-2029)
Table 15. Global Immunoglobulin Sales Quantity by Manufacturers (2018-2023) & (K Pcs)
Table 16. Global Immunoglobulin Sales Quantity Share by Manufacturers (2018-2023)
Table 17. Global Immunoglobulin Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 18. Global Immunoglobulin Revenue Share by Manufacturers (2018-2023)
Table 19. Global Immunoglobulin Price by Manufacturers 2018-2023 (USD/Pcs)
Table 20. Global Key Players of Immunoglobulin, Industry Ranking, 2021 VS 2022
Table 21. Global Immunoglobulin Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Immunoglobulin by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Immunoglobulin as of 2022)
Table 23. Global Key Manufacturers of Immunoglobulin, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Immunoglobulin, Product Offered and Application
Table 25. Global Key Manufacturers of Immunoglobulin, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Immunoglobulin Sales Quantity by Type (2018-2023) & (K Pcs)
Table 28. Global Immunoglobulin Sales Quantity by Type (2024-2029) & (K Pcs)
Table 29. Global Immunoglobulin Sales Quantity Share by Type (2018-2023)
Table 30. Global Immunoglobulin Sales Quantity Share by Type (2024-2029)
Table 31. Global Immunoglobulin Revenue by Type (2018-2023) & (US$ Million)
Table 32. Global Immunoglobulin Revenue by Type (2024-2029) & (US$ Million)
Table 33. Global Immunoglobulin Revenue Share by Type (2018-2023)
Table 34. Global Immunoglobulin Revenue Share by Type (2024-2029)
Table 35. Immunoglobulin Price by Type (2018-2023) & (USD/Pcs)
Table 36. Global Immunoglobulin Price Forecast by Type (2024-2029) & (USD/Pcs)
Table 37. Global Immunoglobulin Sales Quantity by Application (2018-2023) & (K Pcs)
Table 38. Global Immunoglobulin Sales Quantity by Application (2024-2029) & (K Pcs)
Table 39. Global Immunoglobulin Sales Quantity Share by Application (2018-2023)
Table 40. Global Immunoglobulin Sales Quantity Share by Application (2024-2029)
Table 41. Global Immunoglobulin Revenue by Application (2018-2023) & (US$ Million)
Table 42. Global Immunoglobulin Revenue by Application (2024-2029) & (US$ Million)
Table 43. Global Immunoglobulin Revenue Share by Application (2018-2023)
Table 44. Global Immunoglobulin Revenue Share by Application (2024-2029)
Table 45. Immunoglobulin Price by Application (2018-2023) & (USD/Pcs)
Table 46. Global Immunoglobulin Price Forecast by Application (2024-2029) & (USD/Pcs)
Table 47. North America Immunoglobulin Revenue by Company (2018-2023) & (US$ Million)
Table 48. North America Immunoglobulin Sales Quantity by Company (2018-2023) & (K Pcs)
Table 49. North America Immunoglobulin Sales Quantity by Type (2018-2023) & (K Pcs)
Table 50. North America Immunoglobulin Sales Quantity by Type (2024-2029) & (K Pcs)
Table 51. North America Immunoglobulin Revenue by Type (2018-2023) & (US$ Million)
Table 52. North America Immunoglobulin Revenue by Type (2024-2029) & (US$ Million)
Table 53. North America Immunoglobulin Sales Quantity by Application (2018-2023) & (K Pcs)
Table 54. North America Immunoglobulin Sales Quantity by Application (2024-2029) & (K Pcs)
Table 55. North America Immunoglobulin Revenue by Application (2018-2023) & (US$ Million)
Table 56. North America Immunoglobulin Revenue by Application (2024-2029) & (US$ Million)
Table 57. North America Immunoglobulin Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 58. North America Immunoglobulin Revenue by Country (2018-2023) & (US$ Million)
Table 59. North America Immunoglobulin Revenue by Country (2024-2029) & (US$ Million)
Table 60. North America Immunoglobulin Sales Quantity by Country (2018-2023) & (K Pcs)
Table 61. North America Immunoglobulin Sales Quantity by Country (2024-2029) & (K Pcs)
Table 62. Europe Immunoglobulin Sales Quantity by Company (2018-2023) & (K Pcs)
Table 63. Europe Immunoglobulin Revenue by Company (2018-2023) & (US$ Million)
Table 64. Europe Immunoglobulin Sales Quantity by Type (2018-2023) & (K Pcs)
Table 65. Europe Immunoglobulin Sales Quantity by Type (2024-2029) & (K Pcs)
Table 66. Europe Immunoglobulin Revenue by Type (2018-2023) & (US$ Million)
Table 67. Europe Immunoglobulin Revenue by Type (2024-2029) & (US$ Million)
Table 68. Europe Immunoglobulin Sales Quantity by Application (2018-2023) & (K Pcs)
Table 69. Europe Immunoglobulin Sales Quantity by Application (2024-2029) & (K Pcs)
Table 70. Europe Immunoglobulin Revenue by Application (2018-2023) & (US$ Million)
Table 71. Europe Immunoglobulin Revenue by Application (2024-2029) & (US$ Million)
Table 72. Europe Immunoglobulin Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 73. Europe Immunoglobulin Revenue by Country (2018-2023) & (US$ Million)
Table 74. Europe Immunoglobulin Revenue by Country (2024-2029) & (US$ Million)
Table 75. Europe Immunoglobulin Sales Quantity by Country (2018-2023) & (K Pcs)
Table 76. Europe Immunoglobulin Sales Quantity by Country (2024-2029) & (K Pcs)
Table 77. China Immunoglobulin Sales Quantity by Company (2018-2023) & (K Pcs)
Table 78. China Immunoglobulin Revenue by Company (2018-2023) & (US$ Million)
Table 79. China Immunoglobulin Sales Quantity by Type (2018-2023) & (K Pcs)
Table 80. China Immunoglobulin Sales Quantity by Type (2024-2029) & (K Pcs)
Table 81. China Immunoglobulin Revenue by Type (2018-2023) & (US$ Million)
Table 82. China Immunoglobulin Revenue by Type (2024-2029) & (US$ Million)
Table 83. China Immunoglobulin Sales Quantity by Application (2018-2023) & (K Pcs)
Table 84. China Immunoglobulin Sales Quantity by Application (2024-2029) & (K Pcs)
Table 85. China Immunoglobulin Revenue by Application (2018-2023) & (US$ Million)
Table 86. China Immunoglobulin Revenue by Application (2024-2029) & (US$ Million)
Table 87. APAC Immunoglobulin Sales Quantity by Company (2018-2023) & (K Pcs)
Table 88. APAC Immunoglobulin Revenue by Company (2018-2023) & (US$ Million)
Table 89. APAC Immunoglobulin Sales Quantity by Type (2018-2023) & (K Pcs)
Table 90. APAC Immunoglobulin Sales Quantity by Type (2024-2029) & (K Pcs)
Table 91. APAC Immunoglobulin Revenue by Type (2018-2023) & (US$ Million)
Table 92. APAC Immunoglobulin Revenue by Type (2024-2029) & (US$ Million)
Table 93. APAC Immunoglobulin Sales Quantity by Application (2018-2023) & (K Pcs)
Table 94. APAC Immunoglobulin Sales Quantity by Application (2024-2029) & (K Pcs)
Table 95. APAC Immunoglobulin Revenue by Application (2018-2023) & (US$ Million)
Table 96. APAC Immunoglobulin Revenue by Application (2024-2029) & (US$ Million)
Table 97. APAC Immunoglobulin Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 98. APAC Immunoglobulin Revenue by Region (2018-2023) & (US$ Million)
Table 99. APAC Immunoglobulin Revenue by Region (2024-2029) & (US$ Million)
Table 100. APAC Immunoglobulin Sales Quantity by Region (2018-2023) & (K Pcs)
Table 101. APAC Immunoglobulin Sales Quantity by Region (2024-2029) & (K Pcs)
Table 102. Middle East, Africa and Latin America Immunoglobulin Sales Quantity by Company (2018-2023) & (K Pcs)
Table 103. Middle East, Africa and Latin America Immunoglobulin Revenue by Company (2018-2023) & (US$ Million)
Table 104. Middle East, Africa and Latin America Immunoglobulin Sales Quantity by Type (2018-2023) & (K Pcs)
Table 105. Middle East, Africa and Latin America Immunoglobulin Sales Quantity by Type (2024-2029) & (K Pcs)
Table 106. Middle East, Africa and Latin America Immunoglobulin Revenue by Type (2018-2023) & (US$ Million)
Table 107. Middle East, Africa and Latin America Immunoglobulin Revenue by Type (2024-2029) & (US$ Million)
Table 108. Middle East, Africa and Latin America Immunoglobulin Sales Quantity by Application (2018-2023) & (K Pcs)
Table 109. Middle East, Africa and Latin America Immunoglobulin Sales Quantity by Application (2024-2029) & (K Pcs)
Table 110. Middle East, Africa and Latin America Immunoglobulin Revenue by Application (2018-2023) & (US$ Million)
Table 111. Middle East, Africa and Latin America Immunoglobulin Revenue by Application (2024-2029) & (US$ Million)
Table 112. Middle East, Africa and Latin America Immunoglobulin Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 113. Middle East, Africa and Latin America Immunoglobulin Revenue by Country (2018-2023) & (US$ Million)
Table 114. Middle East, Africa and Latin America Immunoglobulin Revenue by Country (2024-2029) & (US$ Million)
Table 115. Middle East, Africa and Latin America Immunoglobulin Sales Quantity by Country (2018-2023) & (K Pcs)
Table 116. Middle East, Africa and Latin America Immunoglobulin Sales Quantity by Country (2024-2029) & (K Pcs)
Table 117. Baxter Company Information
Table 118. Baxter Description and Overview
Table 119. Baxter Immunoglobulin Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 120. Baxter Immunoglobulin Product and Services
Table 121. Baxter Immunoglobulin SWOT Analysis
Table 122. Baxter Recent Developments
Table 123. CSL Company Information
Table 124. CSL Description and Overview
Table 125. CSL Immunoglobulin Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 126. CSL Immunoglobulin Product and Services
Table 127. CSL Immunoglobulin SWOT Analysis
Table 128. CSL Recent Developments
Table 129. Grifols Company Information
Table 130. Grifols Description and Overview
Table 131. Grifols Immunoglobulin Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 132. Grifols Immunoglobulin Product and Services
Table 133. Grifols Immunoglobulin SWOT Analysis
Table 134. Grifols Recent Developments
Table 135. Octapharma Company Information
Table 136. Octapharma Description and Overview
Table 137. Octapharma Immunoglobulin Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 138. Octapharma Immunoglobulin Product and Services
Table 139. Octapharma Immunoglobulin SWOT Analysis
Table 140. Octapharma Recent Developments
Table 141. Biotest Company Information
Table 142. Biotest Description and Overview
Table 143. Biotest Immunoglobulin Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 144. Biotest Immunoglobulin Product and Services
Table 145. Biotest Immunoglobulin SWOT Analysis
Table 146. Biotest Recent Developments
Table 147. China National Pharmaceutical Group Company Information
Table 148. China National Pharmaceutical Group Description and Overview
Table 149. China National Pharmaceutical Group Immunoglobulin Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 150. China National Pharmaceutical Group Immunoglobulin Product and Services
Table 151. China National Pharmaceutical Group Immunoglobulin SWOT Analysis
Table 152. China National Pharmaceutical Group Recent Developments
Table 153. CTBB Company Information
Table 154. CTBB Description and Overview
Table 155. CTBB Immunoglobulin Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 156. CTBB Immunoglobulin Product and Services
Table 157. CTBB Immunoglobulin SWOT Analysis
Table 158. CTBB Recent Developments
Table 159. Hualan Bio Company Information
Table 160. Hualan Bio Description and Overview
Table 161. Hualan Bio Immunoglobulin Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 162. Hualan Bio Immunoglobulin Product and Services
Table 163. Hualan Bio Immunoglobulin SWOT Analysis
Table 164. Hualan Bio Recent Developments
Table 165. RAAS Company Information
Table 166. RAAS Description and Overview
Table 167. RAAS Immunoglobulin Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 168. RAAS Immunoglobulin Product and Services
Table 169. RAAS Immunoglobulin SWOT Analysis
Table 170. RAAS Recent Developments
Table 171. Shanxi Kangbao Biological Company Information
Table 172. Shanxi Kangbao Biological Description and Overview
Table 173. Shanxi Kangbao Biological Immunoglobulin Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 174. Shanxi Kangbao Biological Immunoglobulin Product and Services
Table 175. Shanxi Kangbao Biological Immunoglobulin SWOT Analysis
Table 176. Shanxi Kangbao Biological Recent Developments
Table 177. Shuanglin Bio Pharm Company Information
Table 178. Shuanglin Bio Pharm Description and Overview
Table 179. Shuanglin Bio Pharm Immunoglobulin Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 180. Shuanglin Bio Pharm Immunoglobulin Product and Services
Table 181. Shuanglin Bio Pharm Recent Developments
Table 182. Sichuan Yuanda Shuyang Pharmaceutical Company Information
Table 183. Sichuan Yuanda Shuyang Pharmaceutical Description and Overview
Table 184. Sichuan Yuanda Shuyang Pharmaceutical Immunoglobulin Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 185. Sichuan Yuanda Shuyang Pharmaceutical Immunoglobulin Product and Services
Table 186. Sichuan Yuanda Shuyang Pharmaceutical Recent Developments
Table 187. Boya Bio Company Information
Table 188. Boya Bio Description and Overview
Table 189. Boya Bio Immunoglobulin Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 190. Boya Bio Immunoglobulin Product and Services
Table 191. Boya Bio Recent Developments
Table 192. Jiade Bio Company Information
Table 193. Jiade Bio Description and Overview
Table 194. Jiade Bio Immunoglobulin Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 195. Jiade Bio Immunoglobulin Product and Services
Table 196. Jiade Bio Recent Developments
Table 197. Weilun Bio Company Information
Table 198. Weilun Bio Description and Overview
Table 199. Weilun Bio Immunoglobulin Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 200. Weilun Bio Immunoglobulin Product and Services
Table 201. Weilun Bio Recent Developments
Table 202. Key Raw Materials Lists
Table 203. Raw Materials Key Suppliers Lists
Table 204. Immunoglobulin Distributors List
Table 205. Immunoglobulin Customers List
Table 206. Immunoglobulin Market Trends
Table 207. Immunoglobulin Market Drivers
Table 208. Immunoglobulin Market Challenges
Table 209. Immunoglobulin Market Restraints
Table 210. Research Programs/Design for This Report
Table 211. Key Data Information from Secondary Sources
Table 212. Key Data Information from Primary Sources
List of Figures
Figure 1. Immunoglobulin Product Picture
Figure 2. Global Immunoglobulin Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Immunoglobulin Market Share by Type in 2022 & 2029
Figure 4. Intramuscular Injection Human Immunoglobulin Product Picture
Figure 5. Intravenous Injection Human Immunoglobulin Product Picture
Figure 6. Global Immunoglobulin Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Immunoglobulin Market Share by Application in 2022 & 2029
Figure 8. Prevention of Measles
Figure 9. Infectious Hepatitis
Figure 10. Primary Immunoglobulin Deficiency
Figure 11. Immunoglobulin Report Years Considered
Figure 12. Global Immunoglobulin Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Immunoglobulin Revenue 2018-2029 (US$ Million)
Figure 14. Global Immunoglobulin Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 15. Global Immunoglobulin Sales Quantity 2018-2029 (K Pcs)
Figure 16. Global Immunoglobulin Sales Quantity Market Share by Region (2018-2023)
Figure 17. Global Immunoglobulin Sales Quantity Market Share by Region (2024-2029)
Figure 18. North America Immunoglobulin Sales Quantity YoY (2018-2029) & (K Pcs)
Figure 19. North America Immunoglobulin Revenue YoY (2018-2029) & (US$ Million)
Figure 20. Europe Immunoglobulin Sales Quantity YoY (2018-2029) & (K Pcs)
Figure 21. Europe Immunoglobulin Revenue YoY (2018-2029) & (US$ Million)
Figure 22. China Immunoglobulin Sales Quantity YoY (2018-2029) & (K Pcs)
Figure 23. China Immunoglobulin Revenue YoY (2018-2029) & (US$ Million)
Figure 24. APAC Immunoglobulin Sales Quantity YoY (2018-2029) & (K Pcs)
Figure 25. APAC Immunoglobulin Revenue YoY (2018-2029) & (US$ Million)
Figure 26. Middle East, Africa and Latin America Immunoglobulin Sales Quantity YoY (2018-2029) & (K Pcs)
Figure 27. Middle East, Africa and Latin America Immunoglobulin Revenue YoY (2018-2029) & (US$ Million)
Figure 28. The Top 10 and Top 5 Players Market Share by Immunoglobulin Sales Quantity in 2022
Figure 29. The Top 10 and Top 5 Players Market Share by Immunoglobulin Revenue in 2022
Figure 30. Immunoglobulin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 31. Global Immunoglobulin Sales Quantity Market Share by Type (2018-2029)
Figure 32. Global Immunoglobulin Revenue Market Share by Type (2018-2029)
Figure 33. Global Immunoglobulin Sales Quantity Market Share by Application (2018-2029)
Figure 34. Global Immunoglobulin Revenue Market Share by Application (2018-2029)
Figure 35. North America Immunoglobulin Revenue Market Share by Company in 2022
Figure 36. North America Immunoglobulin Sales Quantity Market Share by Company in 2022
Figure 37. North America Immunoglobulin Sales Quantity Market Share by Type (2018-2029)
Figure 38. North America Immunoglobulin Revenue Market Share by Type (2018-2029)
Figure 39. North America Immunoglobulin Sales Quantity Market Share by Application (2018-2029)
Figure 40. North America Immunoglobulin Revenue Market Share by Application (2018-2029)
Figure 41. North America Immunoglobulin Revenue Share by Country (2018-2029)
Figure 42. North America Immunoglobulin Sales Quantity Share by Country (2018-2029)
Figure 43. U.S. Immunoglobulin Revenue (2018-2029) & (US$ Million)
Figure 44. Canada Immunoglobulin Revenue (2018-2029) & (US$ Million)
Figure 45. Europe Immunoglobulin Sales Quantity Market Share by Company in 2022
Figure 46. Europe Immunoglobulin Revenue Market Share by Company in 2022
Figure 47. Europe Immunoglobulin Sales Quantity Market Share by Type (2018-2029)
Figure 48. Europe Immunoglobulin Revenue Market Share by Type (2018-2029)
Figure 49. Europe Immunoglobulin Sales Quantity Market Share by Application (2018-2029)
Figure 50. Europe Immunoglobulin Revenue Market Share by Application (2018-2029)
Figure 51. Europe Immunoglobulin Revenue Share by Country (2018-2029)
Figure 52. Europe Immunoglobulin Sales Quantity Share by Country (2018-2029)
Figure 53. Germany Immunoglobulin Revenue (2018-2029) & (US$ Million)
Figure 54. France Immunoglobulin Revenue (2018-2029) & (US$ Million)
Figure 55. U.K. Immunoglobulin Revenue (2018-2029) & (US$ Million)
Figure 56. Italy Immunoglobulin Revenue (2018-2029) & (US$ Million)
Figure 57. Russia Immunoglobulin Revenue (2018-2029) & (US$ Million)
Figure 58. China Immunoglobulin Sales Quantity Market Share by Company in 2022
Figure 59. China Immunoglobulin Revenue Market Share by Company in 2022
Figure 60. China Immunoglobulin Sales Quantity Market Share by Type (2018-2029)
Figure 61. China Immunoglobulin Revenue Market Share by Type (2018-2029)
Figure 62. China Immunoglobulin Sales Quantity Market Share by Application (2018-2029)
Figure 63. China Immunoglobulin Revenue Market Share by Application (2018-2029)
Figure 64. APAC Immunoglobulin Sales Quantity Market Share by Company in 2022
Figure 65. APAC Immunoglobulin Revenue Market Share by Company in 2022
Figure 66. APAC Immunoglobulin Sales Quantity Market Share by Type (2018-2029)
Figure 67. APAC Immunoglobulin Revenue Market Share by Type (2018-2029)
Figure 68. APAC Immunoglobulin Sales Quantity Market Share by Application (2018-2029)
Figure 69. APAC Immunoglobulin Revenue Market Share by Application (2018-2029)
Figure 70. APAC Immunoglobulin Revenue Share by Region (2018-2029)
Figure 71. APAC Immunoglobulin Sales Quantity Share by Region (2018-2029)
Figure 72. Japan Immunoglobulin Revenue (2018-2029) & (US$ Million)
Figure 73. South Korea Immunoglobulin Revenue (2018-2029) & (US$ Million)
Figure 74. China Taiwan Immunoglobulin Revenue (2018-2029) & (US$ Million)
Figure 75. Southeast Asia Immunoglobulin Revenue (2018-2029) & (US$ Million)
Figure 76. India Immunoglobulin Revenue (2018-2029) & (US$ Million)
Figure 77. Middle East, Africa and Latin America Immunoglobulin Sales Quantity Market Share by Company in 2022
Figure 78. Middle East, Africa and Latin America Immunoglobulin Revenue Market Share by Company in 2022
Figure 79. Middle East, Africa and Latin America Immunoglobulin Sales Quantity Market Share by Type (2018-2029)
Figure 80. Middle East, Africa and Latin America Immunoglobulin Revenue Market Share by Type (2018-2029)
Figure 81. Middle East, Africa and Latin America Immunoglobulin Sales Quantity Market Share by Application (2018-2029)
Figure 82. Middle East, Africa and Latin America Immunoglobulin Revenue Market Share by Application (2018-2029)
Figure 83. Middle East, Africa and Latin America Immunoglobulin Sales Quantity Share by Country (2018-2029)
Figure 84. Middle East, Africa and Latin America Immunoglobulin Revenue Share by Country (2018-2029)
Figure 85. Brazil Immunoglobulin Revenue (2018-2029) & (US$ Million)
Figure 86. Mexico Immunoglobulin Revenue (2018-2029) & (US$ Million)
Figure 87. Turkey Immunoglobulin Revenue (2018-2029) & (US$ Million)
Figure 88. Israel Immunoglobulin Revenue (2018-2029) & (US$ Million)
Figure 89. GCC Countries Immunoglobulin Revenue (2018-2029) & (US$ Million)
Figure 90. Immunoglobulin Value Chain
Figure 91. Immunoglobulin Production Process
Figure 92. Channels of Distribution (Direct Vs Distribution)
Figure 93. Distributors Profiles
Figure 94. Bottom-up and Top-down Approaches for This Report
Figure 95. Data Triangulation
Figure 96. Key Executives Interviewed
This report focuses on:
► Intelligent insights to take informed business decisions.
► Qualitative and quantitative analysis of the market.
► Market size and forecasts from 2024 to 2030.
► Opportunities for expansion and in-depth market analysis.
► Segmentation and regional revenue forecasts.
► Analysis of the market share and competitive landscape.
► Strategic recommendations for future growth.
You'll also receive:
► A comprehensive market research report in PDF or PPT formats.
► Access to our analysts to learn more about the report and get answers to your specific business questions.
► The option to customize the report to meet your specific needs, such as adding more countries or regions or developing abusiness case to launch a new product.
Contact us today to learn more and get sample report.
Our Research Reports Look Like This
